0001567619-18-004474.txt : 20181024 0001567619-18-004474.hdr.sgml : 20181024 20181024162526 ACCESSION NUMBER: 0001567619-18-004474 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181017 FILED AS OF DATE: 20181024 DATE AS OF CHANGE: 20181024 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Havey Adam CENTRAL INDEX KEY: 0001514588 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-33137 FILM NUMBER: 181136691 MAIL ADDRESS: STREET 1: 2273 RESEARCH BLVD SUITE 400 CITY: ROCKVILLE STATE: MD ZIP: 20853 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Emergent BioSolutions Inc. CENTRAL INDEX KEY: 0001367644 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 141902018 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 400 PROFESSIONAL DR, SUITE 400 CITY: GAITHERSBURG STATE: MD ZIP: 20879 BUSINESS PHONE: 240-631-3200 MAIL ADDRESS: STREET 1: 400 PROFESSIONAL DR, SUITE 400 CITY: GAITHERSBURG STATE: MD ZIP: 20879 4/A 1 doc1.xml FORM 4/A X0306 4/A 2018-10-17 2018-10-19 0 0001367644 Emergent BioSolutions Inc. EBS 0001514588 Havey Adam 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 0 1 0 0 EVP, Business Operations Common Stock 2018-10-17 4 S 0 314 63.50 D 29253 D The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey. This form 4/A is being filed to amend the sales price of the shares. /s/ S. Scott Lieberman, Attorney-in-fact 2018-10-24